Since the year 1996, a growing number of epidemiological studies have tested the association of ADRB3 gene Trp64Arg polymorphism with hypertension risk and the changes of relevant intermediate phenotypes, such as blood pressure, body mass index (BMI) and fasting insulin [4, 11–14]. This evidence concerns the gene ADRB3 and hypertensive disorder.